Erick Wayne DeVinney - 26 Feb 2026 Form 4 Insider Report for Axogen, Inc. (AXGN)

Reporting relationship: Chief Innovation Officer
Issuer ticker: AXGN
Reported as of: 26 Feb 2026
Net transaction value: -$687,003
SEC form: 4
Accepted by SEC: 02 Mar 2026, 18:16:14 UTC
Prior SEC filing: 10 Dec 2025
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Marc Began, as attorney-in-fact for Erick DeVinney

Key filing fact

Erick Wayne DeVinney filed Form 4 for Axogen, Inc. (AXGN) on 02 Mar 2026.

Key facts

This page summarizes Erick Wayne DeVinney's Form 4 filing for Axogen, Inc. (AXGN).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Mar 2026, 18:16.

Change

Previous filing in this sequence was filed on 10 Dec 2025.
Current net transaction value: -$687,003.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001595972 Primary reporting owner

DeVinney Erick Wayne

Relationship: Chief Innovation Officer
Address: 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA
Signature: /s/ Marc Began, as attorney-in-fact for Erick DeVinney
Signature date: 02 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Award

Transaction value: $0
Shares: +33,780
Change %: +14%
Price: $0.000000
Shares after: 274,912
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F1

AXGN transaction

Common Stock

Tax liability

Transaction value: $341,394
Shares: -10,702
Change %: -3.9%
Price: $31.90
Shares after: 264,210
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F2

AXGN transaction

Common Stock

Tax liability

Transaction value: $345,609
Shares: -11,276
Change %: -4.3%
Price: $30.65
Shares after: 252,934
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXGN transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +23,000
Change %
Price: $0.000000
Shares after: 23,000
Date: 26 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,000
Exercise price
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria.

Footnote F2

No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance stock units ("PSUs").

Footnote F3

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

Footnote F5

All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.